Saad A. Khan, MD | Stanford Medicine

Dr. Saad Khan, MD

Claim this profile

Stanford University

Studies Thyroid Cancer
Studies Thyroid Carcinoma
5 reported clinical trials
5 drugs studied

Area of expertise

1

Thyroid Cancer

Saad Khan, MD has run 3 trials for Thyroid Cancer. Some of their research focus areas include:

Stage IV
BRAF negative
Stage III
2

Thyroid Carcinoma

Saad Khan, MD has run 2 trials for Thyroid Carcinoma. Some of their research focus areas include:

Stage IV
BRAF negative
Stage III

Affiliated Hospitals

Image of trial facility.

Stanford University

Image of trial facility.

Stanford Cancer Institute

Clinical Trials Saad Khan, MD is currently running

More about Saad Khan, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Saad Khan, MD has experience with

  • Pembrolizumab
  • EP0031
  • 89Zr-panitumumab IV
  • Panitumumab
  • Abemaciclib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Saad Khan, MD specialize in?

Is Saad Khan, MD currently recruiting for clinical trials?

Are there any treatments that Saad Khan, MD has studied deeply?

What is the best way to schedule an appointment with Saad Khan, MD?

What is the office address of Saad Khan, MD?

Is there any support for travel costs?